Back to Search
Start Over
Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessusIn Vitro and in Macrophages
- Source :
- Antimicrobial Agents and Chemotherapy. 63
- Publication Year :
- 2019
- Publisher :
- American Society for Microbiology, 2019.
-
Abstract
- Due to intrinsic multidrug resistance, pulmonary infections with Mycobacterium abscessus are extremely difficult to treat. Previously, we demonstrated that bedaquiline is highly effective against Mycobacterium abscessus both in vitro and in vivo . Here, we report that verapamil improves the efficacy of bedaquiline activity against M. abscessus clinical isolates and low-level resistant strains, both in vitro and in macrophages.
- Subjects :
- Antitubercular Agents
Mycobacterium Infections, Nontuberculous
Microbial Sensitivity Tests
Drug resistance
Mycobacterium abscessus
Pharmacology
Cell Line
03 medical and health sciences
chemistry.chemical_compound
Bacterial Proteins
In vivo
Drug Resistance, Bacterial
Humans
Medicine
Pharmacology (medical)
Diarylquinolines
Mechanisms of Action: Physiological Effects
030304 developmental biology
0303 health sciences
biology
030306 microbiology
business.industry
Macrophages
Drug Synergism
bacterial infections and mycoses
biology.organism_classification
In vitro
Anti-Bacterial Agents
Multiple drug resistance
Infectious Diseases
Verapamil
chemistry
Mutation
bacteria
Efflux
Bedaquiline
business
medicine.drug
Subjects
Details
- ISSN :
- 10986596 and 00664804
- Volume :
- 63
- Database :
- OpenAIRE
- Journal :
- Antimicrobial Agents and Chemotherapy
- Accession number :
- edsair.doi.dedup.....1247d6f33391c8c7c2c48e8ed9758586
- Full Text :
- https://doi.org/10.1128/aac.00705-19